Français
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
International Journal of Neuropsychopharmacology 2018-Nov

Inhibition of Phosphodiesterase 4 by FCPR03 Alleviates Chronic Unpredictable Mild Stress-induced Depressive-like Behaviors and Prevents Dendritic Spine Loss in Mice Hippocampi.

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Le lien est enregistré dans le presse-papiers
Hui Yu
Jiahong Zhong
Bo Niu
Qiuping Zhong
Jiao Xiao
Jinfeng Xie
Manna Lin
Zhongzhen Zhou
Jiangping Xu
Haitao Wang

Mots clés

Abstrait

UNASSIGNED

Phosphodiesterase 4 (PDE4) is a promising target for developing novel antidepressants. However, prototype PDE4 inhibitors show severe side effects, including nausea and vomiting. FCPR03 is a novel PDE4 inhibitor with little emetic potential. In the present study, we investigated the inhibitory effect of FCPR03 on chronic unpredictable mild stress (CUMS)-induced depressive-like behaviors in mice and explored the underlying mechanisms.

UNASSIGNED

The depression model of mice was established by CUMS. Forced swim test (FST), tail suspension test (TST) and sucrose preference test (SPT) were used to assess depressive-like behaviors. Golgi-staining was utilized to analyze dendritic morphology and spine density. The level of cAMP was measured by ELISA assay. Western blot was used to evaluate protein levels of phosphorylated cAMP-response element binding protein (CREB), protein kinase B (Akt), glycogen synthase kinase-3β (GSK-3β), brain derived neurotrophic factor (BDNF) in both hippocampus and prefrontal cortex. Postsynaptic density protein 95 (PSD95) and synapsin 1 were also detected by Western blot in the hippocampi.

UNASSIGNED

Treatment with FCPR03 (0.5-1.0 mg/kg, i.p.) increased consumption of sucrose in SPT in mice exposed to CUMS. FCPR03 shorten the immobility time in FST and TST without affecting the locomotor activity. Furthermore, CUMS decreased the dendritic spine density and dendritic length in the hippocampus. This change was accompanied by decreased expression of PSD95 and synapsin 1. Interestingly, FCPR03 prevented dendritic spine loss and increased synaptic protein levels. Moreover, the levels of cAMP, phosphorylated CREB and BDNF were elevated in CUMS-challenged mice after treatment with FCPR03. In addition, FCPR03 also enhanced the phosphorylation of both Akt and GSK-3β in mice exposed to CUMS.

UNASSIGNED

The present study suggests that FCPR03 could prevent both depressive-like behaviors and spine loss induced by CUMS in the mice hippocampi.

Rejoignez notre
page facebook

La base de données d'herbes médicinales la plus complète soutenue par la science

  • Fonctionne en 55 langues
  • Cures à base de plantes soutenues par la science
  • Reconnaissance des herbes par image
  • Carte GPS interactive - étiquetez les herbes sur place (à venir)
  • Lisez les publications scientifiques liées à votre recherche
  • Rechercher les herbes médicinales par leurs effets
  • Organisez vos intérêts et restez à jour avec les nouvelles recherches, essais cliniques et brevets

Tapez un symptôme ou une maladie et lisez des informations sur les herbes qui pourraient aider, tapez une herbe et voyez les maladies et symptômes contre lesquels elle est utilisée.
* Toutes les informations sont basées sur des recherches scientifiques publiées

Google Play badgeApp Store badge